NevadaState Snapshot for Children

In this comparison, the NHQR quality measures for Nevada for the most recent data year and the baseline year are compared to the average of all States.

Measures Better Than Average in The Recent Year
Measure Population Recent Year Recent Rate Recent Performance Baseline Year Baseline Rate Baseline Performance
Birth trauma - injury to neonate per 1,000 selected live births Total 2015 1.03 Better than Average 2011 1.89 Average
Measures That Are Average in The Recent Year
Measure Population Recent Year Recent Rate Recent Performance Baseline Year Baseline Rate Baseline Performance
Children ages 19-35 months who received 1 or more doses of measles-mumps-rubella vaccine Total 2015 93.7 Average 2000 88.0 Average
Children ages 19-35 months who received 3 or more doses of polio vaccine Total 2015 92.3 Average 2000 87.3 Average
Adolescents ages 13-15 who received 1 or more doses of meningococcal conjugate vaccine Total 2015 80.2 Average 2008 27.5 Worse than Average
Children ages 19-35 months who received 4 or more doses of diphtheria-tetanus-pertussis vaccine Total 2015 84.7 Average 2000 79.1 Average
Children ages 19-35 months who received 1 or more doses of varicella vaccine Total 2015 92.9 Average 2000 61.4 Worse than Average
Children ages 19-35 months who received 3 or more doses of hepatitis B vaccine Total 2015 91.4 Average 2000 84.6 Worse than Average
Adolescents ages 16-17 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years Total 2015 86.1 Average 2008 47.7 Better than Average
Adolescents ages 16-17 who received 1 or more doses of meningococcal conjugate vaccine Total 2015 74.6 Average 2008 33.6 Average
Adolescent aged 13-15 years who received 3 or more doses of human papillomavirus (HPV) vaccine Total 2015 30.3 Average 2012 17.3 Average
Adolescent males ages 13-15 who received 3 or more doses of human papillomavirus (HPV) vaccine Total 2015 22.9 Average
Adolescents ages 13-15 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years Total 2015 89.7 Average 2008 44.9 Average
Measures Worse Than Average in The Recent Year
Measure Population Recent Year Recent Rate Recent Performance Baseline Year Baseline Rate Baseline Performance
Hospital admissions for short-term complications of diabetes per 100,000 population, children ages 6-17 Total 2015 44.9 Worse than Average 2011 38.3 Worse than Average
Hospital admissions for asthma per 100,000 population, children ages 2-17 Total 2015 109.7 Worse than Average 2011 98.2 Average
Measures With No Performance Data
Measure Population
Adolescent ages 16-17 years who received 3 or more doses of human papillomavirus (HPV) vaccine Total
Adolescents ages 13-15 years (excluding adolescents who have had varicella) vaccinated with at least 2 doses of varicella
Adolescents ages 16-17 years (excluding adolescents who have had varicella) vaccinated with at least 2 doses of varicella
Composite measure: Children ages 19-35 months who received all recommended vaccines
Composite measure: Children who had a doctor's office or clinic visit in the last 6 months whose health providers always listened carefully, explained things clearly, respected what they or their parents had to say, and spent enough time with them, Medicaid